EA200501625A1 - Интерферон-бета при тяжелом остром респираторном синдроме (sars) - Google Patents

Интерферон-бета при тяжелом остром респираторном синдроме (sars)

Info

Publication number
EA200501625A1
EA200501625A1 EA200501625A EA200501625A EA200501625A1 EA 200501625 A1 EA200501625 A1 EA 200501625A1 EA 200501625 A EA200501625 A EA 200501625A EA 200501625 A EA200501625 A EA 200501625A EA 200501625 A1 EA200501625 A1 EA 200501625A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sars
interferon
syndrome
beta
respirator
Prior art date
Application number
EA200501625A
Other languages
English (en)
Other versions
EA008766B1 (ru
Inventor
Джампьеро Де Лука
Original Assignee
Арес Трейдинг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арес Трейдинг С.А. filed Critical Арес Трейдинг С.А.
Publication of EA200501625A1 publication Critical patent/EA200501625A1/ru
Publication of EA008766B1 publication Critical patent/EA008766B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В настоящем изобретении раскрыто применение интерферона (IFN) для производства лекарственного средства, предназначенного для лечения и/или профилактики тяжелого острого респираторного синдрома (SARS).
EA200501625A 2003-04-17 2004-04-06 Интерферон-бета при тяжелом остром респираторном синдроме (sars) EA008766B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101066 2003-04-17
PCT/EP2004/050456 WO2004091653A1 (en) 2003-04-17 2004-04-06 Interferon beta in severe acute respiratory syndrome (sars)

Publications (2)

Publication Number Publication Date
EA200501625A1 true EA200501625A1 (ru) 2006-04-28
EA008766B1 EA008766B1 (ru) 2007-08-31

Family

ID=33185950

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501625A EA008766B1 (ru) 2003-04-17 2004-04-06 Интерферон-бета при тяжелом остром респираторном синдроме (sars)

Country Status (13)

Country Link
US (1) US20070026014A1 (ru)
EP (1) EP1613342A1 (ru)
JP (1) JP2006523655A (ru)
KR (1) KR20050112127A (ru)
CN (1) CN1798572A (ru)
AU (1) AU2004229185A1 (ru)
BR (1) BRPI0409484A (ru)
CA (1) CA2521650A1 (ru)
EA (1) EA008766B1 (ru)
MX (1) MXPA05011170A (ru)
NO (1) NO20055243L (ru)
UA (1) UA81481C2 (ru)
WO (1) WO2004091653A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006528679A (ja) * 2003-04-01 2006-12-21 インターミューン インコーポレイテッド コロナウイルス感染症及びサースを治療するための組成物及び方法
EP1641485A4 (en) * 2003-06-09 2009-06-24 Genome Inst Of Singapore INHIBITION OF SARS CORONAVIRUS INFECTION USING ANTIVIRAL DRUGS CLINICALLY TESTED
US9295669B2 (en) 2010-12-14 2016-03-29 Hoffman La-Roche Inc. Combination therapy for proliferative disorders
CA3180390A1 (en) * 2020-03-27 2021-09-30 Fergus MANFORD Compositions for the treatment of a respiratory condition
US20220125661A1 (en) * 2020-10-22 2022-04-28 Jacob Waterman Patient-Worn Therapeutic Apparatus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
JP5281726B2 (ja) * 1998-05-15 2013-09-04 メルク・シャープ・アンド・ドーム・コーポレーション 慢性Ｃ型肝炎感染を有する、抗ウイルス処置を受けていない患者における、リバビリンおよびインターフェロンαを含む併用療法
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
US20030143199A1 (en) * 2001-10-09 2003-07-31 Carson Dennis A. Use of STAT-6 inhibitors as therapeutic agents
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
US20050137154A1 (en) * 2003-05-16 2005-06-23 Hemispherx Biopharma Treating server acute respiratory syndrome

Also Published As

Publication number Publication date
KR20050112127A (ko) 2005-11-29
EA008766B1 (ru) 2007-08-31
US20070026014A1 (en) 2007-02-01
NO20055243L (no) 2005-11-08
JP2006523655A (ja) 2006-10-19
AU2004229185A1 (en) 2004-10-28
BRPI0409484A (pt) 2006-05-02
MXPA05011170A (es) 2005-12-14
EP1613342A1 (en) 2006-01-11
CN1798572A (zh) 2006-07-05
UA81481C2 (en) 2008-01-10
CA2521650A1 (en) 2004-10-28
WO2004091653A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
HUP0402594A2 (hu) Rapamycint és származékait tartalmazó hatóanyag-leadó rendszerek érbetegségek megelőzésére és kezelésére
HUP0301444A2 (hu) Ribavirin és pegilezett alfa-interferon alkalmazása HCV fertőzés kezelésére szolgáló gyógyszerkészítmény előállítására
IL160420A0 (en) Treating or preventing diabetes with cannabidiol
IL173002A (en) Use of calcitonin in the manufacture of oral medication for the prevention or treatment of osteoarthritis
ATE460942T1 (de) Exendine zur glucagon suppression
EA200600498A1 (ru) Макроциклические пептиды, проявляющие противовирусную активность в отношении вируса гепатита с
ZA200407813B (en) Medicament for preventing and/or treating chronic rejection.
TW200509961A (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
WO2004006756A3 (en) THERAPIES FOR RENAL FAILURE USING INTERFERON-β
AR045870A1 (es) Terapia de combinacion para la infeccion de virus de hepatitis c
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
NO20073632L (no) Behandling av hepatitt C med interferon-beta i en asiatisk populasjon
UY28080A1 (es) Isómeros posicionales del ifn peg alfa 2a
WO2007057436A3 (en) Interferon in influenza
PT1610787E (pt) Associação sinérgica compreendendo roflumilast e um agente anticolinérgico seleccionado de sais de tiotrópio para o tratamento de doenças respiratórias
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
WO2004062684A3 (en) Treatment of thrombocytopenia with inhibitors of pacap
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
WO2004091524A3 (en) Respiratory virus vaccines
EA200501625A1 (ru) Интерферон-бета при тяжелом остром респираторном синдроме (sars)
WO2005123113A3 (en) Interferon compositions and methods of use thereof
DE69918961D1 (de) Verbesserte inhalationspräparate
EA200500774A1 (ru) Новая синергетическая комбинация, включающая рофлумиласт и формотерол
WO2005034853A3 (en) Uses of interferons with altered spatial structure
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU